Director/PDMR Shareholding

RNS Number : 6958G

GlaxoSmithKline PLC

02 July 2012

 



 Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of changes in the directors' interests in the Ordinary Shares and American Depositary Shares (ADSs) of GlaxoSmithKline plc.

On 29 June 2012, the Company's Non-Executive Directors were allocated notional Ordinary Shares at a price of £14.54 per Ordinary Share, and notional ADSs at a price of $45.37 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 April 2012 to 30 June 2012:

Non Executive Director	Ordinary Shares	American Depositary Shares (ADSs)
Sir Christopher Gent	2,321.183
Professor Sir Roy Anderson	580.296
Dr Stephanie Burns		454.703
Stacey Cartwright	322.387
Lawrence Culp		909.406
Sir Crispin Davis	2,149.243
Judy Lewent		227.352
Sir Deryck Maughan		909.406
Dr Daniel Podolsky		876.927
Tom de Swaan	795.220
Sir Robert Wilson	580.296

The Company and the Non-Executive Directors were informed of these allocations on 2 July 2012.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

2 July 2012

 

END

 

 

RDSZLLFBLDFBBBK